Gerresheimer (ETR:GXI) Shares Up 1.4% - Should You Buy?

Gerresheimer AG (ETR:GXI - Get Free Report) was up 1.4% during trading on Thursday . The stock traded as high as €75.95 ($82.55) and last traded at €75.40 ($81.96). Approximately 194,688 shares were traded during trading, an increase of 38% from the average daily volume of 140,925 shares. The stock had previously closed at €74.35 ($80.82).

Gerresheimer Price Performance

The business has a 50-day moving average price of €75.46 and a two-hundred day moving average price of €78.45. The company has a quick ratio of 0.40, a current ratio of 0.80 and a debt-to-equity ratio of 87.94. The company has a market capitalization of $2.50 billion, a price-to-earnings ratio of 21.87, a price-to-earnings-growth ratio of 0.82 and a beta of 0.94.

Gerresheimer Company Profile

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.